Please check your internet connection and try again.
# Megacv Duo (Amoxicillin/Clavulanate)
## Overview
Megacv Duo is a potentiated penicillin antibiotic combining amoxicillin (a beta-lactam) with clavulanate potassium (a beta-lactamase inhibitor). This combination expands the spectrum to include beta-lactamase-producing bacteria (e.g., *Staphylococcus aureus*, *H. influenzae*, *M. catarrhalis*).
## Primary Indications
Commonly used for respiratory tract infections, sinusitis, otitis media, skin/soft tissue infections, and bite wounds. Not effective against MRSA or atypical pathogens.
## Adult Dosing
Standard dosing is typically provided as the amoxicillin component.
* **Mild to Moderate Infections:** 500 mg amoxicillin/125 mg clavulanate every 8 to 12 hours.
* **Severe or Respiratory Tract Infections:** 875 mg amoxicillin/125 mg clavulanate every 12 hours.
* *Note: Extended-release formulas (e.g., 2000 mg amox) require twice-daily dosing and are reserved for specific severe indications.*
## Pediatric Dosing
Dosing is weight-based, strictly utilizing the amoxicillin component.
* **Common Infections:** 20–45 mg/kg/day divided every 8–12 hours.
* **Recurrent/Severe Otitis Media:** 80–90 mg/kg/day in two divided doses to overcome penicillin-resistant *S. pneumoniae*.
* *Maximum:* Do not exceed adult doses. Ensure the clavulanate component does not exceed physiological tolerance (usually kept at a standard ratio).
## Dose Adjustments
* **Renal Impairment:** Adjustments required for CrCl < 30 mL/min. Avoid the 875 mg tablet in patients with severe renal impairment (CrCl < 30 mL/min).
* **Hepatic Impairment:** Use with caution; monitor liver function periodically.
## Contraindications
* History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate.
* Known serious hypersensitivity (anaphylaxis) to any penicillin or beta-lactam.
## Adverse Effects
* **Gastrointestinal:** Diarrhea (most common, often due to clavulanate), nausea, abdominal pain.
* **Hepatic:** Transient elevation of transaminases; rare but serious hepatitis (cholestatic).
* **Other:** Rash (non-allergic "amoxicillin rash" common), yeast infections (candidiasis), *C. difficile*-associated diarrhea.
## Key Drug Interactions
* **Warfarin:** May increase INR and bleeding risk.
* **Methotrexate:** May decrease renal clearance, increasing systemic exposure and toxicity risk.
* **Oral Contraceptives:** May reduce efficacy; backup contraception is often recommended during treatment.
* **Probenecid:** Decreases renal tubular secretion of amoxicillin, increasing blood levels.
## Monitoring
* **Renal/Hepatic:** Periodic LFTs and renal function if using prolonged therapy.
* **Allergic Reaction:** Monitor for rashes or respiratory distress during initial doses.
* **GI:** Monitor for symptoms of *C. difficile* infection (uncontrolled, severe, or bloody diarrhea).
## Clinical Pearls
* **Administration:** Take with food or a meal to improve GI tolerability and absorption.
* **Formulation Warning:** Different concentrations of clavulanate are not interchangeable. Ensure the ratio (e.g., 4:1 vs 7:1) matches the specific indication to prevent diarrhea or therapeutic failure.
* **Resistance:** Excessive use contributes to rising rates of antibiotic resistance. Reserve for confirmed beta-lactamase bacterial infections.
***
*Disclaimer: This information is for educational purposes for healthcare professionals. Always verify the most current prescribing information via the manufacturer’s package insert or official clinical pharmacology databases, as local resistance patterns and clinical protocols supersede general guidelines.*
